Avnet’s year-to-date stock performance.
Avnet: “It’s a really good stock. I’m glad you brought my attention. I cannot believe how low the P/E is. But then again, a lot of people feel that the move is about to end at any given moment, and that’s what’s wrong with Avnet.”
Archer Aviation’s year-to-date stock performance.
Archer Aviation: “Let’s pass on it. If we want to do a spec, there’s better specs out there.”
United Microelectronics’ year-to-date stock performance.
United Microelectronics: “This is a tough one. You know, it’s not expensive, but it’s up 135% [this year]. I just don’t have a catalyst at these prices. I’m going to say no to it right now.”
Altimmune’s year-to-date stock performance.
Altimmune: “I believe the GLPs are going to be able to address [fatty liver] better than anything else. But a $2 stock, count me in. But remember, stocks can go to zero.”
